Novateur Ventures Participates in Founding and Financing of Epitopea, a New Cancer Therapeutics Company
The Newly Founded Company, Epitopea, Has Secured $14 Million in Seed Financing to Advance the Ground-breaking Tumor-Specific Antigen (TSA) Research of Drs. Claude Perreault and Pierre Thibault at the Université… Read More




